• By ICR Secretariat
• Posted Wednesday, February 10, 2021

Multiple rolling reviews kick-off for Novavax’s COVID-19 vaccine

http://www.pharmatimes.com/news/multiple_rolling_reviews_kick-off_for_novavaxs_covid-19_vaccine_1362778

Rolling reviews of Novavax’s COVID-19 vaccine have kicked-off in the UK, US, EU and Canada following the recent announcement that the jab demonstrated 89.3% efficacy in a phase III trial.